| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |